N-methyl-N'-nitro-N-nitrosoguanidine activates multiple cell death mechanisms in human fibroblasts

Michael W Lee1, Wan-Ju Kim, Dillon I Beardsley

  • 1Department of Biochemistry and Molecular Biology and the UF-Shands Cancer Center Program in Cancer Genetics, Epigenetics and Tumor Virology, University of Florida College of Medicine, Gainesville, Florida 32610, USA.

DNA and Cell Biology
|August 7, 2007
PubMed

Insights

Genotoxic stress from MNNG triggers both apoptosis and non-apoptotic cell death in human fibroblasts, regardless of ATM kinase status. Inhibiting PARP or caspase-3 reduces this cytotoxic response.

Area of Science:

  • Cell Biology
  • Genetics
  • Biochemistry

Background:

  • Genotoxic stress can induce distinct cell death pathways, including apoptosis and necrosis.
  • The protein kinase ataxia telangiectasia-mutated (ATM) plays a role in DNA damage response.
  • Human fibroblasts are a model system for studying cellular responses to genotoxic agents.

Purpose of the Study:

  • To investigate the cytotoxic response of human fibroblasts, both ATM-proficient and ATM-deficient, to the alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
  • To elucidate the specific cell death mechanisms activated by MNNG, focusing on apoptosis and non-apoptotic pathways.

Main Methods:

  • Treatment of ATM-proficient (YZ-5) and ATM-deficient (EBS-7) human fibroblasts with MNNG.
  • Assessment of cell viability using long- and short-term assays.
  • Analysis of apoptosis markers: caspase-3 cleavage, nuclear fragmentation, and annexin V staining.
  • Flow cytometry to detect non-apoptotic cell death.
  • Measurement of poly-ADP ribose polymerase (PARP) activity and poly(ADP-ribosylation).
  • Monitoring of apoptosis-inducing factor (AIF) release and translocation.
  • Inhibition of PARP (using DPQ) and caspase-3 (using benzyloxycarbonyl-VAD-fluoromethyl ketone) to assess their roles in MNNG-induced cytotoxicity.

Main Results:

  • Both ATM-proficient and ATM-deficient fibroblasts exhibited a cytotoxic response to MNNG.
  • MNNG treatment induced apoptosis, evidenced by increased caspase-3 activity, nuclear fragmentation, and annexin V staining in both cell lines.
  • A non-apoptotic cell death pathway was also activated, characterized by PARP activation and increased poly(ADP-ribosylation), particularly in ATM-proficient cells.
  • PARP activation was linked to apoptosis-inducing factor release from mitochondria to the nucleus.
  • Inhibition of PARP or caspase-3 significantly reduced the MNNG-induced cytotoxic effect.

Conclusions:

  • MNNG induces a heterogeneous cell death response in human fibroblasts, involving both apoptosis and a non-apoptotic pathway.
  • The ATM kinase status does not abolish the induction of these death pathways by MNNG.
  • Both PARP and caspase-3 play critical roles in mediating MNNG-induced cytotoxicity in human fibroblasts.